313 related articles for article (PubMed ID: 26387544)
1. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.
Meads MB; Fang B; Mathews L; Gemmer J; Nong L; Rosado-Lopez I; Nguyen T; Ring JE; Matsui W; MacLeod AR; Pachter JA; Hazlehurst LA; Koomen JM; Shain KH
Oncogene; 2016 May; 35(21):2723-34. PubMed ID: 26387544
[TBL] [Abstract][Full Text] [Related]
2. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.
Shain KH; Yarde DN; Meads MB; Huang M; Jove R; Hazlehurst LA; Dalton WS
Cancer Res; 2009 Feb; 69(3):1009-15. PubMed ID: 19155309
[TBL] [Abstract][Full Text] [Related]
3. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
4. Pyk2 promotes tumor progression in multiple myeloma.
Zhang Y; Moschetta M; Huynh D; Tai YT; Zhang Y; Zhang W; Mishima Y; Ring JE; Tam WF; Xu Q; Maiso P; Reagan M; Sahin I; Sacco A; Manier S; Aljawai Y; Glavey S; Munshi NC; Anderson KC; Pachter J; Roccaro AM; Ghobrial IM
Blood; 2014 Oct; 124(17):2675-86. PubMed ID: 25217697
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol-3-kinase activation mediates proline-rich tyrosine kinase 2 phosphorylation and recruitment to beta1-integrins in human CD34+ cells.
Melikova S; Dylla SJ; Verfaillie CM
Exp Hematol; 2004 Nov; 32(11):1051-6. PubMed ID: 15539082
[TBL] [Abstract][Full Text] [Related]
6. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.
Nakamura K; Yano H; Schaefer E; Sabe H
Oncogene; 2001 May; 20(21):2626-35. PubMed ID: 11420674
[TBL] [Abstract][Full Text] [Related]
7. Proline-rich tyrosine kinase 2 via enhancing signal transducer and activator of transcription 3-dependent cJun expression mediates retinal neovascularization.
Kumar R; Singh NK; Rao GN
Sci Rep; 2016 May; 6():26480. PubMed ID: 27210483
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.
Alves GF; Aimaretti E; Einaudi G; Mastrocola R; de Oliveira JG; Collotta D; Porchietto E; Aragno M; Cifani C; Sordi R; Thiemermann C; Fernandes D; Collino M
Front Immunol; 2022; 13():837180. PubMed ID: 35178052
[TBL] [Abstract][Full Text] [Related]
9. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
10. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
11. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
12. RAFTK/Pyk2 mediates LPA-induced PC12 cell migration.
Park SY; Schinkmann KA; Avraham S
Cell Signal; 2006 Jul; 18(7):1063-71. PubMed ID: 16199135
[TBL] [Abstract][Full Text] [Related]
13. Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.
Lin L; Yan F; Zhao D; Lv M; Liang X; Dai H; Qin X; Zhang Y; Hao J; Sun X; Yin Y; Huang X; Zhang J; Lu J; Ge Q
Oncotarget; 2016 Mar; 7(9):9844-58. PubMed ID: 26848618
[TBL] [Abstract][Full Text] [Related]
14. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
Burger R; Le Gouill S; Tai YT; Shringarpure R; Tassone P; Neri P; Podar K; Catley L; Hideshima T; Chauhan D; Caulder E; Neilan CL; Vaddi K; Li J; Gramatzki M; Fridman JS; Anderson KC
Mol Cancer Ther; 2009 Jan; 8(1):26-35. PubMed ID: 19139110
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of focal adhesion kinase (FAK) on Ser732 is induced by rho-dependent kinase and is essential for proline-rich tyrosine kinase-2-mediated phosphorylation of FAK on Tyr407 in response to vascular endothelial growth factor.
Le Boeuf F; Houle F; Sussman M; Huot J
Mol Biol Cell; 2006 Aug; 17(8):3508-20. PubMed ID: 16760434
[TBL] [Abstract][Full Text] [Related]
17. Novel Role of Src in Priming Pyk2 Phosphorylation.
Zhao M; Finlay D; Zharkikh I; Vuori K
PLoS One; 2016; 11(2):e0149231. PubMed ID: 26866924
[TBL] [Abstract][Full Text] [Related]
18. A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma.
Amet R; Previtali V; Mihigo HB; Sheridan E; Brophy S; Hante NK; Santos-Martinez MJ; Hayden PJ; Browne PV; Rozas I; McElligott AM; Zisterer DM
Life Sci; 2022 Feb; 290():120236. PubMed ID: 34953891
[TBL] [Abstract][Full Text] [Related]
19. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.
Lim Y; Lim ST; Tomar A; Gardel M; Bernard-Trifilo JA; Chen XL; Uryu SA; Canete-Soler R; Zhai J; Lin H; Schlaepfer WW; Nalbant P; Bokoch G; Ilic D; Waterman-Storer C; Schlaepfer DD
J Cell Biol; 2008 Jan; 180(1):187-203. PubMed ID: 18195107
[TBL] [Abstract][Full Text] [Related]
20. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells.
Sekimoto H; Eipper-Mains J; Pond-Tor S; Boney CM
Mol Endocrinol; 2005 Jul; 19(7):1859-67. PubMed ID: 15761030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
